Jonathan T. Lord's Insider Trades & SAST Disclosures
Jonathan T. Lord's most recent trade in Biolase Inc was a trade of 721,154 Restricted Stock Unit done . Disclosure was reported to the exchange on June 8, 2023.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Jonathan T. Lord.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Biolase Inc | Jonathan T. Lord | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 721,154 | 779,901 | - | - | Restricted Stock Unit | |
| Biolase Inc | Jonathan T. Lord | Director | Sale of securities on an exchange or to another person at price $ 0.75 per share. | 07 Dec 2022 | 3,537 | 59,925 (0%) | 0% | 0.8 | 2,653 | Common Stock |
| Biolase Inc | Jonathan T. Lord | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2022 | 58,747 | 58,747 | - | - | Restricted Stock Unit | |
| Biolase Inc | Jonathan T. Lord | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 28 Apr 2022 | 1,395 | 0 | - | - | Series G Preferred Stock | |
| Biolase Inc | Jonathan T. Lord | Director | Sale of securities on an exchange or to another person at price $ 0.38 per share. | 15 Dec 2021 | 11,038 | 633,096 (2%) | 0% | 0.4 | 4,194 | Common Stock |
| Biolase Inc | Jonathan T. Lord | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2021 | 330,000 | 330,000 | - | - | Restricted Stock Unit | |
| Biolase Inc | Jonathan T. Lord | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2021 | 189,902 | 189,902 | - | - | Stock Appreciation Right | |
| Biolase Inc | Jonathan T. Lord | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2020 | 20,000 | 443,602 | - | - | Restricted Stock Unit | |
| Biolase Inc | Jonathan T. Lord | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jul 2020 | 15,000 | 15,000 | - | - | Warrants | |
| Biolase Inc | Jonathan T. Lord | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jul 2020 | 6 | 6 | - | - | Series F Convertible Preferred |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges